This company has shut down. Modifi Bio is no longer operating — its last tracked round was a Seed in 2023.
Explore the Startup GraveyardModifi Biosciences is a direct DNA modification developing novel cancer therapeutics.
Modifi Bio has raised $4.3M in total funding. The most recent round was Seed. The last funding was announced in October 2023.
Modifi Bio's investors include Connecticut Innovations, Ironwood Capital, National Cancer Institute, HighCape Partners, Pathway Bioventures.
Modifi Bio is headquartered in New Haven, United States.
Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics.
Modifi Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Modifi Bio — Funding & Investors." VCBacked, October 16, 2023, https://www.vcbacked.co/company/modifi-bio. Accessed July 21, 2026.
VCBacked. (2023). Modifi Bio — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/modifi-bio
{{cite web |title=Modifi Bio — Funding & Investors |url=https://www.vcbacked.co/company/modifi-bio |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated